Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.92 USD | -3.82% | -4.02% | -51.32% |
Financials (USD)
Sales 2024 * | 38.74M | Sales 2025 * | 50.93M | Capitalization | 61.51M |
---|---|---|---|---|---|
Net income 2024 * | -87M | Net income 2025 * | -69M | EV / Sales 2024 * | 1.59 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.21 x |
P/E ratio 2024 * |
-0.49
x | P/E ratio 2025 * |
-0.72
x | Employees | 344 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.61% |
Latest transcript on Bionano Genomics, Inc.
1 day | -3.82% | ||
1 week | +4.18% | ||
Current month | +4.18% | ||
1 month | -9.80% | ||
3 months | -17.86% | ||
6 months | -35.66% | ||
Current year | -51.32% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Holmlin
CEO | Chief Executive Officer | 56 | 11-01-11 |
Gülsen Kama
DFI | Director of Finance/CFO | 51 | 23-09-10 |
Shroff Hema
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 18-06-30 | |
David Barker
CHM | Chairman | 82 | 10-05-10 |
Albert Luderer
BRD | Director/Board Member | 75 | 11-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | +8.23% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.92 | -3.82% | 1,265,811 |
24-05-07 | 0.9565 | -4.01% | 706,845 |
24-05-06 | 0.9965 | +4.89% | 839,780 |
24-05-03 | 0.95 | +0.07% | 980,221 |
24-05-02 | 0.9493 | -0.96% | 940,873 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.32% | 63.95M | |
+8.07% | 219B | |
+7.87% | 184B | |
+12.75% | 138B | |
-1.37% | 62.54B | |
+4.88% | 52.22B | |
+11.59% | 51.73B | |
+2.71% | 41.4B | |
+4.90% | 37.17B | |
+23.75% | 31.76B |
- Stock Market
- Equities
- BNGO Stock